Zyprexa

sales of Excluding the impact of exchange rates, sales of increased 9 percent in the fourth quarter.

For the full year of 2005, worldwide U.S.

Excluding the impact of exchange rates, sales of increased 6 percent in 2005.

Diabetes Care Products In the fourth quarter of 2005, diabetes care revenue, composed primarily of Humalog(R), Humulin(R), Actos(R) and recently launched Byetta, increased 11 percent, to $750.4 million, compared with the fourth quarter of 2004.

Diabetes care revenue increased 17 percent in the U.S., to $434.9 million.

Diabetes care revenue outside the U.S.

increased 5 percent, to $315.5 million.

For the full year of 2005, worldwide diabetes care revenue increased 7 percent, to $2.797 billion.

For the fourth quarter of 2005, worldwide Humalog sales increased 9 percent, to $309.1 million, driven primarily by high...

Read more...